vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and BRAND HOUSE COLLECTIVE, INC. (TBHC). Click either name above to swap in a different company.

BRAND HOUSE COLLECTIVE, INC. is the larger business by last-quarter revenue ($103.5M vs $83.1M, roughly 1.2× PROCEPT BioRobotics Corp). BRAND HOUSE COLLECTIVE, INC. runs the higher net margin — -3.6% vs -38.1%, a 34.5% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -9.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -21.0%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Soho House is an international private members’ club with a focus on the media, arts and fashion industries.

PRCT vs TBHC — Head-to-Head

Bigger by revenue
TBHC
TBHC
1.2× larger
TBHC
$103.5M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+29.8% gap
PRCT
20.2%
-9.6%
TBHC
Higher net margin
TBHC
TBHC
34.5% more per $
TBHC
-3.6%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-21.0%
TBHC

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
PRCT
PRCT
TBHC
TBHC
Revenue
$83.1M
$103.5M
Net Profit
$-31.6M
$-3.7M
Gross Margin
64.9%
20.4%
Operating Margin
-4.1%
-1.9%
Net Margin
-38.1%
-3.6%
Revenue YoY
20.2%
-9.6%
Net Profit YoY
-27.9%
51.8%
EPS (diluted)
$-0.56
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
TBHC
TBHC
Q1 26
$83.1M
Q4 25
$76.4M
$103.5M
Q3 25
$83.3M
$75.8M
Q2 25
$79.2M
$81.5M
Q1 25
$69.2M
$148.9M
Q4 24
$68.2M
$114.4M
Q3 24
$58.4M
$86.3M
Q2 24
$53.4M
$91.8M
Net Profit
PRCT
PRCT
TBHC
TBHC
Q1 26
$-31.6M
Q4 25
$-29.8M
$-3.7M
Q3 25
$-21.4M
$-20.2M
Q2 25
$-19.6M
$-11.8M
Q1 25
$-24.7M
$7.9M
Q4 24
$-18.9M
$-7.7M
Q3 24
$-21.0M
$-14.5M
Q2 24
$-25.6M
$-8.8M
Gross Margin
PRCT
PRCT
TBHC
TBHC
Q1 26
64.9%
Q4 25
60.6%
20.4%
Q3 25
64.8%
16.3%
Q2 25
65.4%
24.9%
Q1 25
63.9%
30.3%
Q4 24
64.0%
28.1%
Q3 24
63.2%
20.5%
Q2 24
59.0%
29.5%
Operating Margin
PRCT
PRCT
TBHC
TBHC
Q1 26
-4.1%
Q4 25
-40.6%
-1.9%
Q3 25
-27.8%
-24.7%
Q2 25
-28.0%
-12.9%
Q1 25
-39.7%
6.2%
Q4 24
-28.9%
-2.1%
Q3 24
-38.4%
-15.4%
Q2 24
-50.3%
-8.2%
Net Margin
PRCT
PRCT
TBHC
TBHC
Q1 26
-38.1%
Q4 25
-39.1%
-3.6%
Q3 25
-25.7%
-26.6%
Q2 25
-24.7%
-14.5%
Q1 25
-35.8%
5.3%
Q4 24
-27.6%
-6.7%
Q3 24
-35.9%
-16.8%
Q2 24
-48.0%
-9.6%
EPS (diluted)
PRCT
PRCT
TBHC
TBHC
Q1 26
$-0.56
Q4 25
$-0.54
$-0.16
Q3 25
$-0.38
$-0.90
Q2 25
$-0.35
$-0.54
Q1 25
$-0.45
$0.61
Q4 24
$-0.34
$-0.59
Q3 24
$-0.40
$-1.11
Q2 24
$-0.50
$-0.68

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
TBHC
TBHC
Cash + ST InvestmentsLiquidity on hand
$245.6M
$6.5M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$-44.0M
Total Assets
$487.1M
$229.2M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
TBHC
TBHC
Q1 26
$245.6M
Q4 25
$286.5M
$6.5M
Q3 25
$294.3M
$3.6M
Q2 25
$302.7M
$3.5M
Q1 25
$316.2M
$3.8M
Q4 24
$333.7M
$6.8M
Q3 24
$196.8M
$4.5M
Q2 24
$214.1M
$3.8M
Total Debt
PRCT
PRCT
TBHC
TBHC
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
$64.0M
Q4 24
$51.5M
$85.8M
Q3 24
$51.4M
$61.4M
Q2 24
$51.4M
$47.5M
Stockholders' Equity
PRCT
PRCT
TBHC
TBHC
Q1 26
$347.7M
Q4 25
$365.9M
$-44.0M
Q3 25
$380.3M
$-35.2M
Q2 25
$385.8M
$-16.2M
Q1 25
$389.2M
$-19.0M
Q4 24
$402.2M
$-27.1M
Q3 24
$241.2M
$-19.7M
Q2 24
$251.8M
$-5.5M
Total Assets
PRCT
PRCT
TBHC
TBHC
Q1 26
$487.1M
Q4 25
$508.1M
$229.2M
Q3 25
$511.5M
$221.9M
Q2 25
$513.1M
$225.4M
Q1 25
$519.4M
$242.2M
Q4 24
$534.0M
$279.8M
Q3 24
$374.1M
$266.2M
Q2 24
$374.4M
$242.6M
Debt / Equity
PRCT
PRCT
TBHC
TBHC
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
TBHC
TBHC
Operating Cash FlowLast quarter
$-25.9M
Free Cash FlowOCF − Capex
$-26.8M
FCF MarginFCF / Revenue
-25.9%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-18.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
TBHC
TBHC
Q1 26
Q4 25
$-10.3M
$-25.9M
Q3 25
$-6.6M
$-7.0M
Q2 25
$-15.0M
$-3.1M
Q1 25
$-17.0M
$19.8M
Q4 24
$-32.4M
$-12.6M
Q3 24
$-18.8M
$-12.7M
Q2 24
$-15.7M
$-13.7M
Free Cash Flow
PRCT
PRCT
TBHC
TBHC
Q1 26
Q4 25
$-12.2M
$-26.8M
Q3 25
$-9.5M
$-7.4M
Q2 25
$-17.8M
$-3.6M
Q1 25
$-18.8M
$19.0M
Q4 24
$-33.6M
$-13.1M
Q3 24
$-19.0M
$-13.2M
Q2 24
$-16.8M
$-14.4M
FCF Margin
PRCT
PRCT
TBHC
TBHC
Q1 26
Q4 25
-15.9%
-25.9%
Q3 25
-11.4%
-9.8%
Q2 25
-22.5%
-4.5%
Q1 25
-27.2%
12.8%
Q4 24
-49.2%
-11.5%
Q3 24
-32.6%
-15.2%
Q2 24
-31.4%
-15.7%
Capex Intensity
PRCT
PRCT
TBHC
TBHC
Q1 26
Q4 25
2.4%
0.9%
Q3 25
3.4%
0.6%
Q2 25
3.5%
0.7%
Q1 25
2.7%
0.5%
Q4 24
1.7%
0.4%
Q3 24
0.4%
0.5%
Q2 24
2.0%
0.8%
Cash Conversion
PRCT
PRCT
TBHC
TBHC
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
2.51×
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

TBHC
TBHC

Segment breakdown not available.

Related Comparisons